Case number 2023-2042
Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2025 | 50 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [1100613] [JCA] [Entered: 07/08/2025 09:52 AM] (1) |
| Jul 1, 2025 | 49 | ORDER filed denying Mylan Laboratories Ltd.'s combined petition for panel rehearing and rehearing en banc [47]. By: Per Curiam. Service as of this date by the Clerk of Court. [1099497] [MJL] [Entered: 07/01/2025 10:30 AM] (2) |
| May 29, 2025 | 48 | 13 paper copies of Doc. No. [47],[47] received from Appellant Mylan Laboratories Ltd. [1092809] [JCP] [Entered: 05/29/2025 12:12 PM] (0) |
| May 28, 2025 | 47 | Petition for panel rehearing, for en banc rehearing filed by Appellant Mylan Laboratories Ltd.. Service: 05/28/2025 by email. [1092649] [23-2042] [Deepro Mukerjee] [Entered: 05/28/2025 05:13 PM] (40) |
| May 28, 2025 | 46 | Amended Entry of Appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Jitendra Malik; Eric Werlinger; Jillian Schurr; Timothy Gray as counsel for Appellant Mylan Laboratories Ltd.. Service: 05/28/2025 by email. [1092486] [23-2042] [Deepro Mukerjee] [Entered: 05/28/2025 12:52 PM] (2) |
| Apr 16, 2025 | 45 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [44] filed by Appellant Mylan Laboratories Ltd.. Petition for Rehearing due on or before 05/28/2025. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [1083235] [MVH] [Entered: 04/16/2025 05:01 PM] (2) |
| Apr 11, 2025 | 44 | MOTION of Appellant Mylan Laboratories Ltd. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 05/28/2025. Service: 04/11/2025 by email. [1082143] [23-2042] [Eric Werlinger] [Entered: 04/11/2025 04:53 PM] (10) |
| Mar 28, 2025 | 43 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [1078655] [MVH] [Entered: 03/28/2025 09:45 AM] (1) |
| Mar 28, 2025 | 42 | OPINION filed for the court by Dyk, Circuit Judge; Prost, Circuit Judge and Goldberg, Chief District Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [1078654] [MVH] [Entered: 03/28/2025 09:45 AM] (10) |
| Feb 6, 2025 | 41 | Submitted after ORAL ARGUMENT to Panel: Dyk, Circuit Judge; Prost, Circuit Judge and Goldberg, Judge.Arguing counsel: Eric Thomas Werlinger for Mylan Laboratories Ltd. and Aron Russell Fischer for Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV and Janssen Research and Development LLC.Oral Argument Audio available here. [1067353] [MJL] [Entered: 02/06/2025 01:08 PM] (0) |
| Jan 27, 2025 | 40 | Amended Response to notice of oral argument from Appellant Mylan Laboratories Ltd.. Service: 01/27/2025 by email. [1064117] [23-2042] [Eric Werlinger] [Entered: 01/27/2025 04:22 PM] (1) |
| Dec 31, 2024 | 39 | Response to notice of oral argument from Appellees Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV and Janssen Research and Development LLC. Service: 12/31/2024 by email. [1057915] [23-2042] [Aron Fischer] [Entered: 12/31/2024 01:58 PM] (1) |
| Dec 31, 2024 | 38 | Response to notice of oral argument from Appellant Mylan Laboratories Ltd.. Service: 12/31/2024 by email. [1057856] [23-2042] [Deepro Mukerjee] [Entered: 12/31/2024 12:13 PM] (1) |
| Dec 17, 2024 | 37 | NOTICE OF ORAL ARGUMENT. Panel: 2502K. Case scheduled February 6, 2025. Response to Notice of Oral Argument due: 12/31/2024. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1055094] [MJL] [Entered: 12/17/2024 05:13 PM] (2) |
| Oct 3, 2024 | 36 | Clerk's Note to the File: The court has updated its session calendar for December 2024 through May 2025. Expected arguing counsel should review the revised calendar, available here, to determine whether to file an amended Response to Notice to Advise of Scheduling Conflicts. [1036759] [KMH] [Entered: 10/03/2024 11:17 AM] (0) |
| Apr 8, 2024 | 35 | RESPONSE of Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC to Doc No. [34]. Service: 04/08/2024 by email. [995847] [23-2042] [Barbara Mullin] [Entered: 04/08/2024 06:36 PM] (3) |
| Apr 5, 2024 | 34 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Mylan Laboratories Ltd.. Service: 04/05/2024 by email. [995458] [23-2042] [Deepro Mukerjee] [Entered: 04/05/2024 02:03 PM] (43) |
| Mar 27, 2024 | 33 | The following conflict dates submitted by Aron Russell Fischer for Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV and Janssen Research and Development LLC have been accepted by the court: 07/12/2024, 08/05/2024, 08/06/2024, 08/07/2024, 08/08/2024, 08/09/2024, 09/03/2024. [993230] [MJL] [Entered: 03/27/2024 08:43 AM] (0) |
| Mar 27, 2024 | 32 | The following conflict dates submitted by Eric T. Werlinger for Mylan Laboratories Ltd. have been accepted by the court: 05/08/2024, 05/09/2024, 05/10/2024, 08/09/2024. [993228]--[Edited 03/27/2024 by MJL to correct filer] [MJL] [Entered: 03/27/2024 08:36 AM] (0) |
| Mar 22, 2024 | 31 | Notice from Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC regarding conflicts with oral argument. Service: 03/22/2024 by email. [992330] [23-2042] [Aron Fischer] [Entered: 03/22/2024 10:34 AM] (5) |
| Mar 22, 2024 | 30 | Notice from Appellant Mylan Laboratories Ltd. regarding conflicts with oral argument. Service: 03/22/2024 by email. [992308] [23-2042] [Eric Werlinger] [Entered: 03/22/2024 09:45 AM] (3) |
| Mar 21, 2024 | 29 | 6 paper copies of Doc. No. [25], [20], [10] received from Appellant Mylan Laboratories Ltd.. [992295] [VDW] [Entered: 03/22/2024 09:24 AM] (0) |
| Mar 19, 2024 | 28 | 6 paper copies of Doc. No. [17] received from Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. [991747] [VDW] [Entered: 03/20/2024 10:37 AM] (0) |
| Mar 15, 2024 | 26 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [990852] [JSP] [Entered: 03/15/2024 10:31 AM] (0) |
| Mar 15, 2024 | 27 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [990853] [JSP] [Entered: 03/15/2024 10:32 AM] (1) |
| Mar 14, 2024 | 25 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED by Appellant Mylan Laboratories Ltd.. Service: 03/14/2024 by email. [990565]--[Edited 03/15/2024 by JSP - compliance review complete] [Deepro Mukerjee] [Entered: 03/14/2024 10:00 AM] (0) |
| Mar 13, 2024 | 24 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Mylan Laboratories Ltd., Confidential Appendix [23], is not in compliance with the rules of this court (see attached). Compliant document due on 03/20/2024. Service as of this date by the Clerk of Court. [990297] [JSP] [Entered: 03/13/2024 09:25 AM] (2) |
| Mar 11, 2024 | 23 | CONFIDENTIAL APPENDIX FILED by Appellees Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, Janssen Research and Development LLC and Appellant Mylan Laboratories Ltd.. Service: 03/11/2024 by email. [989780] [23-2042] This document is non-compliant. See Doc No.[24] [Deepro Mukerjee] [Entered: 03/11/2024 01:49 PM] (0) |
| Mar 11, 2024 | 22 | MODIFIED ENTRY: APPENDIX FILED by Appellant Mylan Laboratories Ltd.. Service: 03/11/2024 by fax. [989778] --[Edited 03/13/2024 by JSP - compliance review complete] [Deepro Mukerjee] [Entered: 03/11/2024 01:46 PM] (537) |
| Mar 11, 2024 | 21 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Mylan Laboratories Ltd.. Service: 03/11/2024 by email. [989771] [23-2042] [Deepro Mukerjee] [Entered: 03/11/2024 01:22 PM] (3) |
| Mar 4, 2024 | 20 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Mylan Laboratories Ltd.. Service: 03/04/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [988248] --[Edited 03/05/2024 by JSP - compliance review complete] [Deepro Mukerjee] [Entered: 03/04/2024 07:39 PM] (43) |
| Jan 9, 2024 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file brief [18] filed by Appellant Mylan Laboratories Ltd. The reply brief is due 03/04/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [975431] [JSP] [Entered: 01/09/2024 11:53 AM] (0) |
| Jan 9, 2024 | 18 | MOTION of Appellant Mylan Laboratories Ltd. to extend the time to 03/04/2024 to file brief. Service: 01/09/2024 by email. [975389] [23-2042] [Eric Werlinger] [Entered: 01/09/2024 10:43 AM] (9) |
| Dec 29, 2023 | 17 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 12/29/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [973650] --[Edited 01/03/2024 by JSP - compliance review complete] [Aron Fischer] [Entered: 12/29/2023 12:20 PM] (79) |
| Dec 28, 2023 | 16 | Entry of Appearance for Collin Y. Hong as counsel for Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 12/28/2023 by email. [973474] [23-2042] [Collin Hong] [Entered: 12/28/2023 03:30 PM] (1) |
| Dec 12, 2023 | 15 | Entry of Appearance for Joyce Nadipuram as counsel for Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 12/12/2023 by email. [969513] [23-2042] [Joyce Nadipuram] [Entered: 12/12/2023 11:25 AM] (1) |
| Oct 3, 2023 | 14 | **TEXT ONLY** ORDER granting motion to extend time to file brief [12] filed by Appellees Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV and Janssen Research and Development LLC. The response brief is due 12/29/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [954086] [JCW] [Entered: 10/03/2023 02:06 PM] (0) |
| Oct 2, 2023 | 13 | Entry of Appearance for J. Jay Cho; Lachlan Campbell-Verduyn as counsel for Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 10/02/2023 by email. [953823] [23-2042] [J. Jay Cho] [Entered: 10/02/2023 06:48 PM] (2) |
| Oct 2, 2023 | 12 | MOTION of Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC to extend the time to 12/29/2023 to file brief. Service: 10/02/2023 by email. [953684] [23-2042] [Aron Fischer] [Entered: 10/02/2023 02:18 PM] (10) |
| Sep 20, 2023 | 11 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Mylan Laboratories Ltd.. Service: 09/20/2023 by email. [951388] --[Edited 10/05/2023 by KMH - compliance review complete] [Deepro Mukerjee] [Entered: 09/20/2023 08:56 PM] (190) |
| Sep 20, 2023 | 10 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellant Mylan Laboratories Ltd.. Service: 09/20/2023 by email. [951387]--[Edited 10/05/2023 by KMH - compliance review complete] [Deepro Mukerjee] [Entered: 09/20/2023 08:51 PM] (0) |
| Aug 9, 2023 | 9 | **TEXT ONLY** ORDER granting motion to extend time to file brief [8] filed by Appellant Mylan Laboratories Ltd. The opening brief is due 09/20/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [941768] [JPS] [Entered: 08/09/2023 12:51 PM] (0) |
| Aug 8, 2023 | 8 | MOTION of Appellant Mylan Laboratories Ltd. to extend the time to 09/20/2023 to file brief. Service: 08/08/2023 by email. [941429] [23-2042] [Eric Werlinger] [Entered: 08/08/2023 01:31 PM] (11) |
| Jul 5, 2023 | 7 | Docketing Statement for the Appellant Mylan Laboratories Ltd.. Service: 07/05/2023 by email. [934158] [23-2042] [Deepro Mukerjee] [Entered: 07/05/2023 04:39 PM] (2) |
| Jul 5, 2023 | 6 | Certificate of Interest for Appellant Mylan Laboratories Ltd.. Service: 07/05/2023 by email. [934155] [23-2042] [Deepro Mukerjee] [Entered: 07/05/2023 04:37 PM] (3) |
| Jul 5, 2023 | 5 | Entry of Appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Jitendra Malik; Eric Werlinger; Jillian Schurr; Timothy Gray as counsel for Appellant Mylan Laboratories Ltd.. Service: 07/05/2023 by email. [934154] [23-2042] [Deepro Mukerjee] [Entered: 07/05/2023 04:35 PM] (2) |
| Jun 30, 2023 | 4 | Docketing Statement for the Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 06/30/2023 by email. [933554] [23-2042] [Barbara Mullin] [Entered: 06/30/2023 01:11 PM] (2) |
| Jun 30, 2023 | 3 | Certificate of Interest for Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 06/30/2023 by email. [933553] [23-2042] [Barbara Mullin] [Entered: 06/30/2023 01:10 PM] (3) |
| Jun 30, 2023 | 2 | Entry of Appearance for Barbara L. Mullin; Aron R. Fischer; Andrew D. Cohen as counsel for Appellees Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. and Janssen Research and Development LLC. Service: 06/30/2023 by email. [933552] [23-2042] [Barbara Mullin] [Entered: 06/30/2023 01:01 PM] (2) |
| Jun 20, 2023 | 1 | Appeal docketed. Received: 06/13/2023. [931018]Entry of Appearance due 07/05/2023. Certificate of Interest is due on 07/05/2023. Docketing Statement due 07/05/2023. Appellant/Petitioner's brief is due 08/21/2023. [KMH] [Entered: 06/20/2023 12:50 PM] (28) |
